FDA Approval Insights: Dostarlimab in dMMR Advanced Endometrial Cancer
Season 8, Episode 36, Apr 13, 2023, 06:00 PM
Dr Gilbert discusses the FDA approval of dostarlimab in patients with endometrial cancer, key efficacy data from the GARNET trial, and how this agent bolsters the endometrial cancer treatment paradigm.